- $27.94m
- $24.36m
- $9.56m
- 91
- 76
- 41
- 79
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.69 | 2.74 | 2.8 | 6.59 | 9.56 |
Cost of Revenue | |||||
Gross Profit | 1.75 | 1.82 | 1.93 | 5.31 | 7.84 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.68 | 2.8 | 2.57 | 3.71 | 4.72 |
Operating Profit | 0.008 | -0.064 | 0.228 | 2.88 | 4.83 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.013 | -0.099 | 0.156 | 2.86 | 4.83 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.013 | -0.099 | 0.156 | 2.86 | 4.66 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.013 | -0.099 | 0.156 | 2.86 | 4.66 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.013 | -0.099 | 0.156 | 2.86 | 4.66 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.006 | -0.049 | 0.042 | 1.59 | 2.52 |